Evaluation of the Diagnostic and Prognostic Efficacy of MRI in Acute Sensorineural Hearing Loss and Ménière's Disease
NCT06278129 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 64
Last updated 2024-02-26
Summary
Evaluation of the diagnostic and prognostic efficacy of nuclear magnetic resonance imaging in patients with acute sensorineural hearing loss or in patients suffering from probable or definite MD. The neuroradiological and audiological evaluation are held on in the same day in order to better clarify the radiological and clinical correlates.
Conditions
- Sudden Sensorineural Hearing Loss
- Meniere Disease
- Ménière's Vertigo
- Meniere's Disease Aggravated
- Inner Ear Disease
Interventions
- DIAGNOSTIC_TEST
-
Vestibular myogenic potentials
observational study
Sponsors & Collaborators
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-06-19
- Primary Completion
- 2021-04-23
- Completion
- 2025-12-31
Countries
- Italy
Study Locations
More Related Trials
-
Blood Markers in Adult Patients With Sudden Sensorineural Hearing Loss (SSNHL)
NCT03919474 ·Status: COMPLETED
-
Diagnostic of Various Ototoxicity Induced by Cancer Treatment
NCT06490029 ·Status: RECRUITING
-
Stress Management Therapy for Meniere's Disease
NCT01099046 ·Status: UNKNOWN ·Phase: NA
-
Tinnitus Measured by MEG and Synchronous Neural Interaction™ Test: Template Development
NCT01185990 ·Status: UNKNOWN
-
Vestibular Rehabilitation With Intratympanic Drug Therapy in Meniere's Disease
NCT05355610 ·Status: UNKNOWN ·Phase: NA
-
Transcutaneous Auricular Vagus Nerve Stimulation for Meniere Disease
NCT05328895 ·Status: COMPLETED ·Phase: NA
-
Transcutaneous Auricular Vagus Nerve Stimulation Treatment on Meniere Disease
NCT04686695 ·Status: COMPLETED ·Phase: NA
-
Assessment of The Efficacy of Intratympanic Platelet Rich Plasma for Treatment of Sensorineural Hearing Loss.
NCT05786378 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Intratympanic Injection of Dexamethasone With Hyaluronic Acid in Treatment of Sudden Sensorineural Hearing Loss
NCT06878599 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Transcutaneous Auricular Vagus Nerve Stimulation for Meniere Disease
NCT06544590 ·Status: COMPLETED
-
Prevalence of Peripheral Neuropathy Among Patients With Auditory Neuropathy
NCT06041360 ·Status: UNKNOWN
-
CNS Infections Effect on the Inner Ear
NCT03715569 ·Status: UNKNOWN
-
Audiovestibular Function in Infratentorial Superficial Siderosis
NCT04200664 ·Status: COMPLETED
-
Prognosis of Vestibular Dysfunction in Patients With Idiopathic Sudden Sensorineural Hearing Loss
NCT03951584 ·Status: COMPLETED
-
Sleep Disorders and Their Impact on Patients With Ménière's Disease
NCT07299578 ·Status: RECRUITING
-
Deep Phenotyping of Hearing Instability Disorders: Cohort Establishment, Biomarker Identification, Development of Novel Phenotyping Measures, and Discovery of Therapeutic Targets
NCT04806282 ·Status: RECRUITING
-
Efficacy and Safety of AC102 Compared to Steroids in Adults With Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL)
NCT05776459 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Efficacy of AM 101 in Patients With Acute Inner Ear Tinnitus
NCT00860808 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Endolymphatic Sac Drainage With Steroids for Meniere's Disease
NCT00500474 ·Status: COMPLETED ·Phase: NA
-
Laser Acupuncture for Meniere Disease
NCT06544434 ·Status: RECRUITING ·Phase: PHASE2
-
Clinical Performance of a New Implant System for Bone Conduction Hearing
NCT03086135 ·Status: COMPLETED ·Phase: NA
-
AM-101 in the Treatment of Acute Tinnitus 3
NCT02040194 ·Status: COMPLETED ·Phase: PHASE3
-
Cochlear Implantation Among Adults and Older Children With Unilateral or Asymmetric Hearing Loss
NCT02105441 ·Status: COMPLETED
-
Evaluation of the CochSyn Test Prototype to Measure Cochlear Synaptopathy
NCT06114680 ·Status: TERMINATED ·Phase: NA
-
Open Label Study of OTO-104 in Subjects With Meniere's Disease
NCT02740387 ·Status: TERMINATED ·Phase: PHASE2